The boom­ing Boston/Cam­bridge biotech hub claims an in­dus­try-lead­ing role — no­body beats it at rais­ing record amounts of mon­ey

If there’s one thing that the biotech hub crowd in Boston/Cam­bridge is par­tic­u­lar­ly good at, it’s rais­ing mon­ey. Af­ter cre­at­ing one of the biggest con­cen­tra­tions of drug de­vel­op­ment op­er­a­tions in the world in and around greater Boston, the mon­ey-rais­ing side of the busi­ness is now hum­ming like a well-oiled ma­chine.

In a new in­dus­try hub snap­shot out this morn­ing, the Mass­a­chu­setts Biotech­nol­o­gy Coun­cil — bet­ter known as Mass­Bio — hap­pi­ly boast­ed about the fact that 48% of all US biotech IPOs oc­curred in­side the state in 2017. In 2016, it was 30%. 

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER